5A72.0ICD-11 MMS 2026-01
Primary hyperaldosteronism
Index terms
- Primary hyperaldosteronism
- Aldosteronism
- Conn syndrome
Show allHide
- idiopathic aldosteronism
- primary aldosteronism
- primary aldosteronism due to adrenal hyperplasia
- primary aldosteronism due to bilateral adrenal hyperplasia
- Familial hyperaldosteronism
- Familial hyperaldosteronism type 1
- Dexamethasone sensitive hypertension
- FH1 - [Familial hyperaldosteronism type 1]
- GRA - [Glucocorticoid-remediable aldosteronism]
- Glucocorticoid sensitive hypertension
- Glucocorticoid-remediable aldosteronism
- Hereditary hyperaldosteronism type 1
- Primary hyperaldosteronism, glucocorticoid-sensitive
- Familial hyperaldosteronism type 2
- FH2 - [Familial hyperaldosteronism type 2]
- Familial adrenal adenoma
- Hereditary hyperaldosteronism type 2
- Primary hyperaldosteronism, glucocorticoid-resistant
- Familial hyperaldosteronism type 3
- Nonfamilial primary hyperaldosteronism
- Nonhereditary primary hyperaldosteronism
- Aldosterone-producing adenoma
- APA - [aldosterone-producing adenoma]
- Aldosterone-secreting adenoma
- Conn adenoma
- Primary aldosteronism due to Conn adenoma
- Aldosterone-producing carcinoma
- Pure APAC - [aldosterone-producing adrenocortical carcinoma]
- Pure aldosterone-producing adrenocortical carcinoma
- Pure aldosterone-secreting adrenocortical carcinoma
- Idiopathic hyperaldosteronism
- Primary bilateral adrenal hyperplasia
- Primary unilateral adrenal hyperplasia
- Aldosteronism with hyperplasia of the adrenal cortex
Exclusions from above levels
18– Pregnancy, childbirth or the puerperium- http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn
Sibling codes
Foundation entity
Primary hyperaldosteronism – http://id.who.int/icd/entity/197924221
Allowed postcoordination axes
Part of: 5A72: Hyperaldosteronism › 05: Endocrine, nutritional or metabolic diseases